SCHEMBL22928677

SCHEMBL22928677

CC(C)C(C)c1ccc2c(c1)NC(=O)C2=O

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CES1 P23141 6/20 0.51
TGM2 P21980 6/20 0.50
MAOA P21397 6/20 0.47
MAOB P27338 6/20 0.47
BCHE P06276 1/20 0.41
ALDH1A1 P00352 1/20 0.40
PDE3B Q13370 1/20 0.39
PDE3A Q14432 1/20 0.39
CASP3 P42574 1/20 0.37
CASP2 P42575 1/20 0.37
CASP7 P55210 1/20 0.37
CASP6 P55212 1/20 0.37
CASP8 Q14790 1/20 0.37
EGFR P00533 1/20 0.37
ERBB2 P04626 1/20 0.37
IGF1R P08069 1/20 0.37
PDGFRB P09619 1/20 0.37
GLB1 P16278 1/20 0.37
CTRC Q99895 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8714236 0.86 CES1 (0.55) CES1TGM2MAOAMAOBBCHE
SCHEMBL30398896 0.74 CES1 (0.62) CES1TGM2MAOAMAOBBCHE
SCHEMBL4192180 0.74 CES1 (0.62) CES1TGM2MAOAMAOBBCHE
SCHEMBL22961903 0.71 HPGD (0.44) CES1TGM2MAOAMAOBALDH1A1
SCHEMBL4444879 0.71 TGM2 (0.55) CES1TGM2MAOAMAOBALDH1A1
SCHEMBL11701605 0.71 CES1 (0.50) CES1TGM2MAOAMAOBBCHE
SCHEMBL13594800 0.71 MAOA (0.58) CES1TGM2MAOAMAOBBCHE
SCHEMBL9498049 0.71 ELANE (0.53) CES1MAOABCHEALDH1A1CASP3
SCHEMBL29721579 0.71 ELANE (0.53) CES1MAOABCHEALDH1A1CASP3
SCHEMBL16111115 0.70 CES1 (0.53) CES1TGM2MAOAMAOBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210024498-A1 TETRAHYDROPYRROLE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF MEDICONNS SHANGHAI BIOPHARMACEUTICAL CO LTD (CN) 2021-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210024498-A1 TETRAHYDROPYRROLE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF PRLHR, DRD2, AVPR2 CES1 2454/4885TGM2 3786/4885MAOA 1717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.